文章名稱(chēng)引用次數(shù)

• Targeting FLT3 mutations in AML: review of current knowledge and evidence113
• Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome96
• Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet93
• The MLL recombinome of acute leukemias in 201790
• Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity88
• Clinical use of lentiviral vectors86
• Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia62
• Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion52
• A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis50
• Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond47